Development Status of a Hydrophobic Heavy Metal Chelator/Antioxidant | Boyd Haley, PhD, MIAOMT

Development Status of a Hydrophobic Heavy Metal Chelator/Antioxidant for the Detoxification of Chronically Exposed Individuals | Boyd Haley, PhD, MIAOMT

IAOMT Annual Conference in Stowe, VT.
September 8, 2018

Learning Objectives:
1. To develop an understanding of the multiple ways that mercury disrupts the normal
metabolism of mammalians.
2. To understand the necessary multifactorial considerations for successful treatment and
reversal of mercury toxicity in mammals.
3. To understand the relationship of mercury toxicity to illnesses of the central nervous system.

Dr. Haley obtained his MS in Chemistry at the University of Idaho and his PhD in Chemistry/Biochemistry at Washington State University. He was appointed as Chair and Professor of Chemistry from 1996 to 2005 at the University of Kentucky. He retired in July 2008. He has lectured throughout the world and testified before Congressional Committees and the Institute of Medicine regarding various aspects of mercury toxicity and neurological diseases. In the past six years, he has dedicated most of his research efforts towards the development of a safe and effective chelator for mercury, lead, cadmium and other toxic heavy metals.

Disclaimer: The information provided on this video is not intended as medical advice and should not be interpreted as such. If you seek medical advice, please consult with a health care professional. Also, the information in this video represents the thoughts of the individual speaker/s, and the views expressed in this interview do not necessarily reflect the views of the IAOMT, its individual members, its Executive Committee, its Scientific Advisory Council, its administration, its employees, contractors, sponsors, or any other IAOMT affiliates.